Insight Molecular Diagnostics, Inc. (IMDX)

6.55 +0.18 (+2.83%) USD  |  NASDAQ  |  Dec 29, 16:00
6.50 -0.05 (-0.76%) After-Hours: 18:14
More

Insight Molecular Diagnostics Amortization Expense CF (% of Quarterly Assets)

Amortization Expense CF (% of Quarterly Assets) Chart

View Amortization Expense CF (% of Quarterly Assets) for IMDX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Amortization Expense CF (% of Quarterly Assets) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years

View Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Amortization Expense CF (% of Quarterly Assets) Benchmarks

View Amortization Expense CF (% of Quarterly Assets) Benchmarks
Start Trial
FONAR Corp. Upgrade
XWELL, Inc. Upgrade
ProPhase Labs, Inc. Upgrade
Veracyte, Inc. Upgrade
Exagen, Inc. --